Haemophilus influenzae type b disease in the era of conjugate vaccines: critical factors for successful eradication
M Slack, S Esposito, H Haas, A Mihalyi… - Expert Review of …, 2020 - Taylor & Francis
Introduction Prior to implementation of Haemophilus influenzae type b (Hib)-conjugate
vaccination programs in the 1990s, Hib was the commonest cause of bacterial meningitis in …
vaccination programs in the 1990s, Hib was the commonest cause of bacterial meningitis in …
A review of the DTaP-IPV-HB-PRP-T Hexavalent vaccine in pediatric patients
A Dakin, R Borrow, PD Arkwright - Expert Review of Vaccines, 2023 - Taylor & Francis
Introduction Hexaxim is a hexavalent vaccine approved as primary and booster vaccination
in infants 6 weeks and older, protecting against diphtheria, tetanus, pertussis, poliomyelitis …
in infants 6 weeks and older, protecting against diphtheria, tetanus, pertussis, poliomyelitis …
Lagging Immune Response to Haemophilus influenzae Serotype b (Hib) Conjugate Vaccine after the Primary Vaccination with Hib of Infants in The Netherlands
L Schouls, C Schot, RM de Voer, F van der Klis, M Knol… - Vaccines, 2020 - mdpi.com
In 1993, a Haemophilus influenzae serotype b (Hib) conjugate vaccine was introduced in
the Dutch national immunization program, resulting in a sharp decrease in invasive Hib …
the Dutch national immunization program, resulting in a sharp decrease in invasive Hib …